Pages
Subscribe to my blog
-
Recent Blog Posts
- Independent Review of the Therapeutic Goods Advertising Framework: Recommendations
- Complementary medicine weight loss products complaints submitted to the TGA in 2018-2019. Follow-up.
- Towards independence from commercial interests in health
- TGA stakeholder survey 2019
- The TGA and COVID-19: Starting to use its compliance teeth!
- COVID-19 Scams – ABC update on MMSAustralia
Themes
- ABC
- ACCC
- advertisments
- AHPRA
- AMHC
- AMI
- Blackmores
- Chiropractic Board
- Complaint Resolution Panel
- consumers
- CRP
- Dr Jacqui Forrester
- Dr Tom Goyer
- food-medicine interface
- Friends of Science in Medicine
- FSANZ
- FSM
- Geoff Jowett
- Health Practitioner Regulation National Law Act
- health professionals
- homeopathic medicines
- Ian Rossborough
- La Trobe University
- Medical Weightloss Institute
- Medicines Australia
- MMD Review
- Monash University
- MWI
- Pharmacare Laboratories
- promotion
- Regulatory Reform
- self-regulation
- Senate Community Affairs Legislation Committee
- Souvenaid
- Swisse
- Swisse Vitamins
- TGA
- TGACC
- TGA Complaint system
- TGACRP
- Therapeutic Goods Act
- Therapeutic Goods Advertising Code
- Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017
- Transparency
- U3A
Archives
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- October 2019
- September 2019
- August 2019
- July 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- January 2015
- December 2014
- November 2014
- October 2014
- July 2014
- March 2014
- February 2014
- January 2014
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- May 2012
- April 2012
- March 2012
- June 2011
Subscribe2
Tag Archives: Nurofen
ACCC targets alleged false and misleading Nurofen claims
In 2010 CHOICE (Australian Consumers Association) awarded Nurofen caplets targeting migraine, back, tension headache and period pain a Shonky award. In 2011 the Therapeutic Goods Advertising Complaint Resolution Panel (CRP) upheld a complaint by Professor Paul Rolan that the claims … Continue reading
Posted in Pharmaceutical Promotion
Tagged ACCC, Complaint Resolution Panel, Nurofen, TGA
Leave a comment
CRP upholds complaints (again) about Nurofen “targeted relief”
For a nice depiction of the claims (and their craziness) see: ABC TV The Checkout: Episode 5 Also: https://theconversation.com/tga-failure-gives-nurofen-consumers-a-headache-8762 And: https://theconversation.com/targeted-pain-relief-or-targeted-marketing-the-truth-hurts-13798 The CRP’s determination is available here. A summary follows: Complaints 2012-08-010 and 2012-10-024: Nurofen Back Pain, Nurofen Migraine Pain, Nurofen Period … Continue reading